Nexxen CFO sells 200 shares under 10b5-1 plan

Nexxen International Ltd. Chief Financial Officer Niri Sagi reported an open-market sale of 200 shares of common stock at $8.70 per share on June 12, 2026.

Rhea-AI Filing Summary

Nexxen International Ltd. Chief Financial Officer Niri Sagi reported an open-market sale of 200 shares of common stock at $8.70 per share on June 12, 2026. The filing shows he held 494,850 shares directly after the transaction, so he retained nearly all of his position. The sales were effected under a pre-arranged Rule 10b5-1 trading plan adopted on August 19, 2025, indicating the trades were scheduled in advance rather than timed discretionarily.

Insights

Equity compensation and insider trading analyst

CFO’s small, pre-planned sale looks routine and not thesis-changing.

CFO Niri Sagi executed an open-market sale of 200 Nexxen International common shares at $8.70. After the trade, he directly held 494,850 shares, so the filing shows he kept virtually all of his equity exposure.

The footnote states the sale was effected under a Rule 10b5-1 trading plan adopted on August 19, 2025. Such plans pre-schedule trades, which generally reduces the informational value of the trade’s timing. With no derivative exercises or large dispositions reported, this appears to be a routine, planned liquidity event rather than a strategic repositioning.

Insider Trade Summary 10b5-1

Net Seller: 200 shares

Net Sell 1 txn

Insider Niri Sagi

Role Chief Financial Officer

Sold 200 shs ($2K)

Type	Security	Shares	Price	Value
Sale	Common Stock	200	$8.70	$2K

Holdings After Transaction: Common Stock — 494,850 shares (Direct)

Footnotes (1)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025.

Key Figures

Shares sold: 200 shares Sale price: $8.70 per share Shares held after transaction: 494,850 shares +3 more

6 metrics

Shares sold 200 shares Open-market sale of common stock on June 12, 2026

Sale price $8.70 per share Price for the 200 common shares sold

Shares held after transaction 494,850 shares Direct ownership by CFO following the sale

Net shares sold 200 shares Net-sell direction in transaction summary

Transaction code S Sale in open market or private transaction

Trading plan adoption date August 19, 2025 Adoption date of Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, open-market sale, Form 4, non-derivative

4 terms

Rule 10b5-1 trading plan regulatory

"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

non-derivative financial

""transaction_type": "non-derivative""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Nexxen International (NEXN) disclose for CFO Niri Sagi?

Nexxen International disclosed that CFO Niri Sagi sold 200 shares of common stock in an open-market transaction at $8.70 per share on June 12, 2026. This sale was reported on a Form 4 insider trading report.

How many Nexxen International (NEXN) shares does the CFO hold after this Form 4 sale?

After the reported sale, CFO Niri Sagi directly holds 494,850 shares of Nexxen International common stock. This indicates he maintained a substantial position following the relatively small open-market sale disclosed in the filing.

Was the Nexxen International (NEXN) CFO’s share sale under a Rule 10b5-1 plan?

Yes. The Form 4 footnote states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by CFO Niri Sagi on August 19, 2025. Rule 10b5-1 plans pre-schedule trades, making their timing less discretionary.

Does the Nexxen International (NEXN) Form 4 show any option exercises or derivative trades?

No. The Form 4 transaction involves non-derivative common stock only, with an open-market sale of 200 shares. The derivativeSummary section is empty, indicating no option exercises or other derivative transactions were reported in this filing.

Is the Nexxen International (NEXN) CFO’s Form 4 transaction a buy or a sell?

The Form 4 reports a sell transaction. Specifically, it shows an open-market sale (transaction code S) of 200 shares of Nexxen International common stock at a price of $8.70 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Niri Sagi

(Last) (First) (Middle)

82 YIGAL ALON STREET

(Street)

TEL AVIV 6789124

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nexxen International Ltd. [ NEXN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		S(1)		200	D	$8.7	494,850	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025.

	/s/ Shai Shulman	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)